Corvex, Inc.

The current price of MOVE is $5.26 — it has decreased by 17.81% since the previous close. Data as of Nov 5, 2026.

MOVE is down 24.32% over the past week, down 53.66% over the past month and down 0.75% over the past year. The price is below its 200-day moving average of $13.03.

Analysts' average 12-month price target for MOVE is $18.75, which implies 256.46% upside from the current price. Individual estimates range from $18.75 to $18.75.

Of the 1 analyst covering Corvex, Inc., 1 rates it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Corvex, Inc. has a market capitalization of $165.96M. The company belongs to the Technology sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Corvex, Inc. posted a loss of $5.12 per share against an estimate of -$3.17, missing expectations by 61.51%. Upcoming reports are listed in the earnings calendar.

Corvex, Inc. reported revenue of $3.8M in its most recent quarter, which has increased by 3,590.29% compared with the same quarter a year earlier. Analysts had expected $6.71M.

Corvex, Inc. has not paid any dividends over the past year.

Companies most comparable to Corvex, Inc. include Pasithea Therapeutics Corp., HeartSciences Inc., ENDRA Life Sciences Inc., Aclarion, Inc. and GRI Bio, Inc.

In the latest trading session MOVE moved between $5.11 and $6.50, a range of 26.43% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Corvex, Inc. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Corvex, Inc. is sell. Technical ratings are indicators, not investment advice.

Over the past 52 weeks MOVE has traded between $4.67 and $34.87. The current price is 84.92% below its 52-week high.